Literature DB >> 33991295

Using lipid profiling to better characterize metabolic differences in apolipoprotein E (APOE) genotype among community-dwelling older Black men.

Megan M Marron1, Steven C Moore2, Stacy G Wendell3, Robert M Boudreau4, Iva Miljkovic4, Akira Sekikawa4, Anne B Newman4,5.   

Abstract

Apolipoprotein E (APOE) allelic variation is associated with differences in overall circulating lipids and risks of major health outcomes. Lipid profiling provides the opportunity for a more detailed description of lipids that differ by APOE, to potentially inform therapeutic targets for mitigating higher morbidity and mortality associated with certain APOE genotypes. Here, we sought to identify lipids, lipid-like molecules, and important mediators of fatty acid metabolism that differ by APOE among 278 Black men ages 70-81. Using liquid chromatography-mass spectrometry methods, 222 plasma metabolites classified as lipids, lipid-like molecules, or essential in fatty acid metabolism were detected. We applied principal factor analyses to calculate a factor score for each main lipid category. APOE was categorized as ε4 carriers (n = 83; ε3ε4 or ε4ε4), ε2 carriers (n = 58; ε2ε3 or ε2ε2), or ε3 homozygotes (n = 137; ε3ε3). Using analysis of variance, the monoacylglycerol factor, cholesterol ester factor, the factor for triacylglycerols that consist mostly of polyunsaturated fatty acids, sphingosine, and free carnitine significantly differed by APOE (p < 0.05, false discovery rate < 0.30). The monoacylglycerol factor, cholesterol ester factor, and sphingosine were lower, whereas the factor for triacylglycerols that consisted mostly of polyunsaturated fatty acids was higher among ε2 carriers than remaining participants. Free carnitine was lower among ε4 carriers than ε3 homozygotes. Lower monoacylglycerols and cholesteryl esters and higher triacylglycerols that consist mostly of polyunsaturated fatty acids may be protective metabolic characteristics of APOE ε2 carriers, whereas lower carnitine may reflect altered mitochondrial functioning among ε4 carriers in this cohort of older Black men.
© 2021. American Aging Association.

Entities:  

Keywords:  APOE; Apolipoprotein E; Lipids; Metabolism; Metabolites

Mesh:

Substances:

Year:  2021        PMID: 33991295      PMCID: PMC9135949          DOI: 10.1007/s11357-021-00382-6

Source DB:  PubMed          Journal:  Geroscience        ISSN: 2509-2723            Impact factor:   7.581


  43 in total

1.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

2.  Fatty acid-based lipidomics and membrane remodeling induced by apoE3 and apoE4 in human neuroblastoma cells.

Authors:  Paraskevi Prasinou; Ioannis Dafnis; Giorgia Giacometti; Carla Ferreri; Angeliki Chroni; Chryssostomos Chatgilialoglu
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-07-06       Impact factor: 3.747

Review 3.  Association of apolipoprotein E genotypes with lipid levels and coronary risk.

Authors:  Anna M Bennet; Emanuele Di Angelantonio; Zheng Ye; Frances Wensley; Anette Dahlin; Anders Ahlbom; Bernard Keavney; Rory Collins; Björn Wiman; Ulf de Faire; John Danesh
Journal:  JAMA       Date:  2007-09-19       Impact factor: 56.272

4.  Incidence and prevalence of dementia in the Cardiovascular Health Study.

Authors:  Annette L Fitzpatrick; Lewis H Kuller; Diane G Ives; Oscar L Lopez; William Jagust; John C S Breitner; Beverly Jones; Constantine Lyketsos; Corinne Dulberg
Journal:  J Am Geriatr Soc       Date:  2004-02       Impact factor: 5.562

5.  NLRP3 inflammasome activation drives tau pathology.

Authors:  Christina Ising; Carmen Venegas; Shuangshuang Zhang; Hannah Scheiblich; Susanne V Schmidt; Ana Vieira-Saecker; Stephanie Schwartz; Shadi Albasset; Róisín M McManus; Dario Tejera; Angelika Griep; Francesco Santarelli; Frederic Brosseron; Sabine Opitz; James Stunden; Maximilian Merten; Rakez Kayed; Douglas T Golenbock; David Blum; Eicke Latz; Luc Buée; Michael T Heneka
Journal:  Nature       Date:  2019-11-20       Impact factor: 49.962

6.  Reproducibility of metabolomic profiles among men and women in 2 large cohort studies.

Authors:  Mary K Townsend; Clary B Clish; Peter Kraft; Chen Wu; Amanda L Souza; Amy A Deik; Shelley S Tworoger; Brian M Wolpin
Journal:  Clin Chem       Date:  2013-07-29       Impact factor: 8.327

7.  Metabolic Predictors of Incident Coronary Heart Disease in Women.

Authors:  Nina P Paynter; Raji Balasubramanian; Franco Giulianini; Dong D Wang; Lesley F Tinker; Shuba Gopal; Amy A Deik; Kevin Bullock; Kerry A Pierce; Justin Scott; Miguel A Martínez-González; Ramon Estruch; JoAnn E Manson; Nancy R Cook; Christine M Albert; Clary B Clish; Kathryn M Rexrode
Journal:  Circulation       Date:  2018-02-20       Impact factor: 29.690

Review 8.  Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy.

Authors:  Guojun Bu
Journal:  Nat Rev Neurosci       Date:  2009-04-02       Impact factor: 34.870

9.  HMDB 4.0: the human metabolome database for 2018.

Authors:  David S Wishart; Yannick Djoumbou Feunang; Ana Marcu; An Chi Guo; Kevin Liang; Rosa Vázquez-Fresno; Tanvir Sajed; Daniel Johnson; Carin Li; Naama Karu; Zinat Sayeeda; Elvis Lo; Nazanin Assempour; Mark Berjanskii; Sandeep Singhal; David Arndt; Yonjie Liang; Hasan Badran; Jason Grant; Arnau Serra-Cayuela; Yifeng Liu; Rupa Mandal; Vanessa Neveu; Allison Pon; Craig Knox; Michael Wilson; Claudine Manach; Augustin Scalbert
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

10.  Marked elevation in plasma trimethylamine-N-oxide (TMAO) in patients with mitochondrial disorders treated with oral l-carnitine.

Authors:  H D Vallance; A Koochin; J Branov; A Rosen-Heath; T Bosdet; Z Wang; S L Hazen; G Horvath
Journal:  Mol Genet Metab Rep       Date:  2018-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.